Our 17th Call for proposals in now open!
US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
Doing research on malaria or NTDs? Request the Pathogen Box, free of charge.
shipped free of charge to scientists around the world to boost drug discovery for neglected diseases
in preclinical and clinical development
validated since 1999
MMV Board Member recognized for services to science
A message from MMV's CEO, David Reddy
Leading journal Science publishes details of MMV-supported research
New approaches for an old disease
